208 related articles for article (PubMed ID: 33663323)
1. Urinary calprotectin, NGAL, and KIM-1 in the differentiation of primarily inflammatory vs. non-inflammatory stable chronic kidney diseases.
Seibert FS; Sitz M; Passfall J; Haesner M; Laschinski P; Buhl M; Bauer F; Rohn B; Babel N; Westhoff TH
Ren Fail; 2021 Dec; 43(1):417-424. PubMed ID: 33663323
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Urinary Calprotectin, NGAL and KIM-1 in Chronic Kidney Disease.
Seibert FS; Sitz M; Passfall J; Haesner M; Laschinski P; Buhl M; Bauer F; Babel N; Pagonas N; Westhoff TH
Kidney Blood Press Res; 2018; 43(4):1255-1262. PubMed ID: 30078006
[TBL] [Abstract][Full Text] [Related]
3. Urinary biomarkers for the differentiation of prerenal and intrinsic pediatric acute kidney injury.
Westhoff JH; Fichtner A; Waldherr S; Pagonas N; Seibert FS; Babel N; Tönshoff B; Bauer F; Westhoff TH
Pediatr Nephrol; 2016 Dec; 31(12):2353-2363. PubMed ID: 27286687
[TBL] [Abstract][Full Text] [Related]
4. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
[TBL] [Abstract][Full Text] [Related]
5. Calprotectin and neutrophil gelatinase-associated lipocalin in the differentiation of pre-renal and intrinsic acute kidney injury.
Seibert FS; Pagonas N; Arndt R; Heller F; Dragun D; Persson P; Schmidt-Ott K; Zidek W; Westhoff TH
Acta Physiol (Oxf); 2013 Apr; 207(4):700-8. PubMed ID: 23336369
[TBL] [Abstract][Full Text] [Related]
6. Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.
Lobato GR; Lobato MR; Thomé FS; Veronese FV
Braz J Med Biol Res; 2017 Mar; 50(5):e6106. PubMed ID: 28380198
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers in the prediction of contrast media induced nephropathy - the BITCOIN study.
Seibert FS; Heringhaus A; Pagonas N; Rudolf H; Rohn B; Bauer F; Timmesfeld N; Trappe HJ; Babel N; Westhoff TH
PLoS One; 2020; 15(7):e0234921. PubMed ID: 32673348
[TBL] [Abstract][Full Text] [Related]
8. Urine NGAL and KIM-1: tubular injury markers in acute lymphoblastic leukemia survivors.
Latoch E; Konończuk K; Taranta-Janusz K; Muszyńska-Rosłan K; Szymczak E; Wasilewska A; Krawczuk-Rybak M
Cancer Chemother Pharmacol; 2020 Dec; 86(6):741-749. PubMed ID: 33052454
[TBL] [Abstract][Full Text] [Related]
9. Urinary Biomarkers KIM-1 and NGAL for Detection of Chronic Kidney Disease of Uncertain Etiology (CKDu) among Agricultural Communities in Sri Lanka.
De Silva PM; Mohammed Abdul KS; Eakanayake EM; Jayasinghe SS; Jayasumana C; Asanthi HB; Perera HS; Chaminda GG; Chandana EP; Siribaddana SH
PLoS Negl Trop Dis; 2016 Sep; 10(9):e0004979. PubMed ID: 27643785
[TBL] [Abstract][Full Text] [Related]
10. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).
Peralta CA; Katz R; Bonventre JV; Sabbisetti V; Siscovick D; Sarnak M; Shlipak MG
Am J Kidney Dis; 2012 Dec; 60(6):904-11. PubMed ID: 22749388
[TBL] [Abstract][Full Text] [Related]
11. Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy.
Neuhaus J; Bauer F; Fitzner C; Hilgers RD; Seibert F; Babel N; Doevelaar A; Eitner F; Floege J; Rauen T; Westhoff TH
Kidney Blood Press Res; 2018; 43(5):1563-1572. PubMed ID: 30347407
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
Bhavsar NA; Köttgen A; Coresh J; Astor BC
Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin.
Ghadrdan E; Ebrahimpour S; Sadighi S; Chaibakhsh S; Jahangard-Rafsanjani Z
J Oncol Pharm Pract; 2020 Oct; 26(7):1643-1649. PubMed ID: 32046578
[TBL] [Abstract][Full Text] [Related]
14. Urinary Calprotectin Differentiates Between Prerenal and Intrinsic Acute Renal Allograft Failure.
Seibert FS; Rosenberger C; Mathia S; Arndt R; Arns W; Andrea H; Pagonas N; Bauer F; Zidek W; Westhoff TH
Transplantation; 2017 Feb; 101(2):387-394. PubMed ID: 26901081
[TBL] [Abstract][Full Text] [Related]
15. Role of urinary NGAL and KIM-1 as biomarkers of early kidney injury in obese prepubertal children.
Polidori N; Giannini C; Salvatore R; Pelliccia P; Parisi A; Chiarelli F; Mohn A
J Pediatr Endocrinol Metab; 2020 Sep; 33(9):1183-1189. PubMed ID: 32845866
[TBL] [Abstract][Full Text] [Related]
16. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG
Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704
[TBL] [Abstract][Full Text] [Related]
17. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
[TBL] [Abstract][Full Text] [Related]
18. Serially assessed bisphenol A and phthalate exposure and association with kidney function in children with chronic kidney disease in the US and Canada: A longitudinal cohort study.
Jacobson MH; Wu Y; Liu M; Attina TM; Naidu M; Karthikraj R; Kannan K; Warady BA; Furth S; Vento S; Trachtman H; Trasande L
PLoS Med; 2020 Oct; 17(10):e1003384. PubMed ID: 33052911
[TBL] [Abstract][Full Text] [Related]
19. Value of urinary KIM-1 and NGAL combined with serum Cys C for predicting acute kidney injury secondary to decompensated cirrhosis.
Lei L; Li LP; Zeng Z; Mu JX; Yang X; Zhou C; Wang ZL; Zhang H
Sci Rep; 2018 May; 8(1):7962. PubMed ID: 29784944
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
